Literature DB >> 6127373

Dopamine metabolism increases in post-mortem schizophrenic basal ganglia.

M Toru, T Nishikawa, N Mataga, M Takashima.   

Abstract

The dopamine-rich regions of post-mortem brains from 6 schizophrenics and 7 controls were analyzed. There were no significant changes in dopamine concentrations in basal ganglia and nucleus accumbens of schizophrenics compared with controls. Schizophrenic basal ganglia (putamen and caudate) showed significantly higher levels of homovanillic acid, and tyrosine hydroxylase activity. Among the schizophrenic patients, markedly high activity of tyrosine hydroxylase was measured in a patient diagnosed as catatonic type. He had not taken antipsychotic drugs for 3 months prior to death. In his relatives, three other schizophrenics were found to the second degree. A remarkable low level of dopamine and a high level of homovanillic acid measured indicate this case would have had an increased turnover rate of dopamine in the dopaminergic nerve terminals. Among the schizophrenic patients, there might be one group whose enzyme activity of dopamine synthesis in the brain is exceptionally high.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127373     DOI: 10.1007/bf01254928

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  17 in total

1.  Antipsychotic drug action in schizophrenic patients: effect on cortical dopamine metabolism after long-term treatment.

Authors:  N C Bacopoulos; E G Spokes; E D Bird; R H Roth
Journal:  Science       Date:  1979-09-28       Impact factor: 47.728

2.  Abnormal movements and prognosis in schizophrenia.

Authors:  P E Yarden; W J Discipio
Journal:  Am J Psychiatry       Date:  1971-09       Impact factor: 18.112

3.  3H-Spiperone binding in normal and schizophrenic post-mortem human brain.

Authors:  A V Mackay; A Doble; E D Bird; E G Spokes; M Quik; L L Iversen
Journal:  Life Sci       Date:  1978-08-07       Impact factor: 5.037

4.  Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains.

Authors:  T Lee; P Seeman; W W Tourtellotte; I J Farley; O Hornykeiwicz
Journal:  Nature       Date:  1978-08-31       Impact factor: 49.962

5.  Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.

Authors:  M Toru; N Mataga; M Takashima; T Nishikawa
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 6.  Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature.

Authors:  R Adolfsson; C G Gottfries; B E Roos; B Winblad
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

7.  Monoamine mechanisms in chronic schizophrenia: post-mortem neurochemical findings.

Authors:  T J Crow; H F Baker; A J Cross; M H Joseph; R Lofthouse; A Longden; F Owen; G J Riley; V Glover; W S Killpack
Journal:  Br J Psychiatry       Date:  1979-03       Impact factor: 9.319

8.  Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography.

Authors:  T Nagatsu; K Oka; T Kato
Journal:  J Chromatogr       Date:  1979-07-21

9.  Monoamines and monoamine metabolites in brains from demented schizophrenics.

Authors:  B Winblad; G Bucht; C G Gottfries; B E Roos
Journal:  Acta Psychiatr Scand       Date:  1979-07       Impact factor: 6.392

10.  Increased dopamine-receptor sensitivity in schizophrenia.

Authors:  F Owen; A J Cross; T J Crow; A Longden; M Poulter; G J Riley
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

View more
  7 in total

1.  Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics.

Authors:  Y Kiuchi; T Kobayashi; J Takeuchi; H Shimizu; H Ogata; M Toru
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

2.  Uncovering the role of the nucleus accumbens in schizophrenia: A postmortem analysis of tyrosine hydroxylase and vesicular glutamate transporters.

Authors:  Lesley A McCollum; Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2015-09-18       Impact factor: 4.939

Review 3.  Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia.

Authors:  Urs Meyer; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2009-03-11       Impact factor: 4.530

4.  Serotonergic hyperinnervation and effective serotonin blockade in an FGF receptor developmental model of psychosis.

Authors:  Ilona Klejbor; Aaron Kucinski; Scott R Wersinger; Thomas Corso; Jan H Spodnik; Jerzy Dziewiatkowski; Janusz Moryś; Renae A Hesse; Kenner C Rice; Robert Miletich; Ewa K Stachowiak; Michal K Stachowiak
Journal:  Schizophr Res       Date:  2009-07-01       Impact factor: 4.939

5.  Dopamine neurons in the ventral tegmental area: an autopsy case of disorganized type of schizophrenia.

Authors:  Keiko Ikemoto; Tatsuro Oda; Akiyoshi Nishimura; Katsuji Nishi
Journal:  Case Rep Neurol Med       Date:  2011-09-22

6.  Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome.

Authors:  Sergiu P Paşca; Thomas Portmann; Irina Voineagu; Masayuki Yazawa; Aleksandr Shcheglovitov; Anca M Paşca; Branden Cord; Theo D Palmer; Sachiko Chikahisa; Seiji Nishino; Jonathan A Bernstein; Joachim Hallmayer; Daniel H Geschwind; Ricardo E Dolmetsch
Journal:  Nat Med       Date:  2011-11-27       Impact factor: 53.440

7.  Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology.

Authors:  Amira Ben Afia; Èlia Vila; Belén Ramos; Borja Garcia-Bueno; Karina S MacDowell; Aida Ormazabal; Juan C Leza; Josep M Haro; Rafael Artuch
Journal:  J Neuroinflammation       Date:  2021-09-12       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.